Skip to main content

Vascular Disease: Ischemic Stroke

  • Chapter
Prognosis of Neurological Diseases

Abstract

Ischemic stroke is a sudden onset of focal neurological deficit lasting >24 h and attributable to ischemia.

Its incidence is 240–600/100,000 people. Older age, hypertension, diabetes, lipids, cardiac diseases, smoke, and obesity are risk factors. Stroke causes about 9 % of death around the world. About a quarter of stroke patients die within a month, a third by 6 months, and a half by 1 year. Of the stroke survivors, 16 % are institutionalized, 31 % dependent on self-care, and 20 % on mobility. A particularly poor prognosis is related to the so-called malignant middle cerebral artery syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke. 2009;40:2276–93.

    Article  PubMed  Google Scholar 

  2. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–223.

    Article  PubMed  Google Scholar 

  3. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245–54.

    Google Scholar 

  4. Sacco RL, Benjamin EJ, Broderick JP, et al. American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke. Risk factors. Stroke. 1997;28:1507–17.

    Article  CAS  PubMed  Google Scholar 

  5. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371:1612–23.

    Article  CAS  PubMed  Google Scholar 

  6. Bevan S, Markus HS. Genetics of common polygenic ischaemic stroke: current understanding and future challenges. Stroke Res Treat. 2011;2011:179061.

    PubMed Central  PubMed  Google Scholar 

  7. Opherk C, Peters N, Herzog J, et al. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain. 2004;127:2533–9.

    Article  PubMed  Google Scholar 

  8. Bersano A, Ballabio E, Bresolin N, Candelise L. Genetic polymorphisms for the study of multifactorial stroke. Hum Mutat. 2008;29:776–95.

    Article  CAS  PubMed  Google Scholar 

  9. Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2013;9:CD000197.

    Google Scholar 

  10. Kaste M. Stroke: advances in thrombolysis. Lancet Neurol. 2013;12:2–4.

    Article  PubMed  Google Scholar 

  11. Ciccone A, del Zoppo GJ. Evolving role of endovascular treatment of acute ischemic stroke. Curr Neurol Neurosci Rep. 2014;14:416.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Wijdicks EF, Sheth KN, Carter BS, et al. American Heart Association Stroke Council. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart. Stroke. 2014;45(4):1222–38.

    Google Scholar 

  13. Jüttler E, Unterberg A, Woitzik J, et al. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med. 2014;370:1091–100.

    Article  PubMed  Google Scholar 

  14. Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebralinfarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8:326–33.

    Article  PubMed  Google Scholar 

  15. Geurts M, van der Worp HB, Kappelle LJ, et al. Surgical decompression for space-occupying cerebralinfarction: outcomes at 3 years in the randomized HAMLET trial. Stroke. 2013;44:2506–8.

    Article  PubMed  Google Scholar 

  16. Wu TC, Grotta JC. Hypothermia for acute ischaemic stroke. Lancet Neurol. 2013;12:275–84.

    Article  CAS  PubMed  Google Scholar 

  17. Furie KL, Kasner SE, Adams RJ, et al. American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2011;42:227–76.

    Google Scholar 

  18. Eikelboom JW, Hart RG. Anticoagulant therapy in acute brain ischaemia. Lancet Neurol. 2013;12:526–7.

    Article  CAS  PubMed  Google Scholar 

  19. Bersano A, Ballabio E, Lanfranconi S, et al. Statins and stroke. Curr Med Chem. 2008;15:2380–92.

    Article  CAS  PubMed  Google Scholar 

  20. Rerkasem K, Rothwell PM. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev. 2011;(4):CD001081.

    Google Scholar 

  21. Carotid Stenting Trialists' Collaboration, Bonati LH, Dobson J, et al. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet. 2010;376:1062–73.

    Article  Google Scholar 

  22. Raman G, Moorthy D, Hadar N, et al. Management strategies for asymptomatic carotid stenosis: a systematic review and meta-analysis. Ann Intern Med. 2013;158:676–85.

    Article  PubMed  Google Scholar 

  23. Hankey GJ. An optimum blood pressure target after lacunar stroke? Lancet. 2013;382:482–4.

    Article  PubMed  Google Scholar 

  24. Hankey GJ. Secondary stroke prevention. Lancet Neurol. 2014;13:178–94.

    Article  PubMed  Google Scholar 

  25. Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke. 2000;31:2080–6.

    Article  CAS  PubMed  Google Scholar 

  26. Mohan KM, Wolfe CD, Rudd AG, et al. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke. 2011;42:1489–94.

    Article  PubMed  Google Scholar 

  27. Chandratheva A, Geraghty OC, Luengo-Fernandez R, et al. ABCD2 score predicts severity rather than risk of early recurrent events after transient ischemic attack. Stroke. 2010;41:851–6.

    Article  PubMed  Google Scholar 

  28. Piyaskulkaew C, Singh T, Szpunar S, et al. CHA(2)DS(2)-VASc versus CHADS(2) for stroke risk assessment in low-risk patients with atrial fibrillation: a pilot study from a single center of the NCDR-PINNACLE registry. J Thromb Thrombolysis. 2014;37:400–3.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anna Bersano MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Italia

About this chapter

Cite this chapter

Bersano, A., Caputi, L., Parati, E.A. (2015). Vascular Disease: Ischemic Stroke. In: Sghirlanzoni, A., Lauria, G., Chiapparini, L. (eds) Prognosis of Neurological Diseases. Springer, Milano. https://doi.org/10.1007/978-88-470-5755-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5755-5_1

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5754-8

  • Online ISBN: 978-88-470-5755-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics